Epidemiology of HIV drug resistance in low- and middle-income countries and WHO global strategy to monitor its emergence

Purpose of review This review summarises the latest information of the epidemiology of HIV drug resistance (HIVDR) in low- and middle-income countries and the updated WHO global strategy for HIVDR surveillance and monitoring. Recent findings Finding from recent national-representative surveys show a rise in pretreatment drug resistance (PDR) to reverse transcriptase inhibitors and especially to the class of nonnucleoside reverse transcriptase inhibitors. Levels of PDR are especially high in infants
Source: Current Opinion in HIV and AIDS - Category: Infectious Diseases Tags: HIV DRUG RESISTANCE: CURRENT KNOWLEDGE AND EXISTING GAPS: Edited by Mike Kozal and Rami Kantor Source Type: research